Re: Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine, historical cohort study: authors' response

David Shasha; Anthony D. Heymann; Galia Zacay

doi:10.1016/j.cmi.2021.12.010

Re: Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine, historical cohort study: authors' response

David Shasha^*, Anthony D. Heymann, Galia Zacay

^*Corresponding author for this work

Clinical Departments

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	454-455
Number of pages	2
Journal	Clinical Microbiology and Infection
Volume	28
Issue number	3
DOIs	https://doi.org/10.1016/j.cmi.2021.12.010
State	Published - Mar 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.cmi.2021.12.010

Cite this

@article{653334615c564a17a10aa6001ad2d31d,

title = "Re: Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine, historical cohort study: authors' response",

author = "David Shasha and Heymann, {Anthony D.} and Galia Zacay",

note = "Funding Information: D.S. reports receiving personal fees from Pfizer, outside the submitted work (advisory board on Trumenba) and consultation fees from GSK and Gilead. The other authors declare no competing interests. This study received no funding.",

year = "2022",

month = mar,

doi = "10.1016/j.cmi.2021.12.010",

language = "אנגלית",

volume = "28",

pages = "454--455",

journal = "Clinical Microbiology and Infection",

issn = "1198-743X",

publisher = "Elsevier Ltd.",

number = "3",

}

TY - JOUR

T1 - Re

T2 - Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine, historical cohort study: authors' response

AU - Shasha, David

AU - Heymann, Anthony D.

AU - Zacay, Galia

N1 - Funding Information: D.S. reports receiving personal fees from Pfizer, outside the submitted work (advisory board on Trumenba) and consultation fees from GSK and Gilead. The other authors declare no competing interests. This study received no funding.

PY - 2022/3

Y1 - 2022/3

UR - http://www.scopus.com/inward/record.url?scp=85126147955&partnerID=8YFLogxK

U2 - 10.1016/j.cmi.2021.12.010

DO - 10.1016/j.cmi.2021.12.010

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 34923127

AN - SCOPUS:85126147955

SN - 1198-743X

VL - 28

SP - 454

EP - 455

JO - Clinical Microbiology and Infection

JF - Clinical Microbiology and Infection

IS - 3

ER -

Re: Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine, historical cohort study: authors' response

UN SDGs

Access to Document

Other files and links

Cite this